| P2093 | author name string | Minh Nguyen | |
| | Tim Clackson | |
| | Victor M Rivera | |
| | Guang Huan-Tu | |
| | Karin U Jooss | |
| | Melissa Gonzalez-Edick | |
| | Thomas C Harding | |
| P2860 | cites work | Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model. | Q44426807 |
| | Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. | Q45500358 |
| | Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial | Q45693906 |
| | Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. | Q45854837 |
| | Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands | Q45887107 |
| | Rapamycin for immunosuppression in organ allografting. | Q64891783 |
| | Angiostatin induces and sustains dormancy of human primary tumors in mice | Q71101907 |
| | VEGF-Trap: a VEGF blocker with potent antitumor effects | Q24535043 |
| | Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy | Q24535690 |
| | Current development of mTOR inhibitors as anticancer agents | Q28255366 |
| | A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance | Q33769618 |
| | Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers | Q33782809 |
| | Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain | Q34142832 |
| | Subthalamic GAD gene therapy in a Parkinson's disease rat model | Q34154186 |
| | AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. | Q34168942 |
| | Dimerizer-regulated gene expression | Q35012915 |
| | From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy | Q35180997 |
| | Long-term regulated expression of growth hormone in mice after intramuscular gene transfer | Q35559776 |
| | Gene therapy progress and prospects: transcription regulatory systems. | Q35676294 |
| | Regulatable gene expression systems for gene therapy applications: progress and future challenges | Q36157542 |
| | Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands | Q36617985 |
| | The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites | Q36779415 |
| | Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs | Q39097277 |
| | Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. | Q39719268 |
| | AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma | Q40297313 |
| | Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats | Q40380857 |
| | The cryptic life style of adeno-associated virus | Q40524042 |
| | Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy | Q40596034 |
| | IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector | Q40863150 |
| | Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins | Q41044142 |
| | Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector | Q41057898 |
| | Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. | Q43727676 |
| | Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor | Q43873032 |
| | Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. | Q44088681 |
| P433 | issue | 5 | |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| P304 | page(s) | 912-920 | |
| P577 | publication date | 2007-01-23 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Rapamycin-regulated control of antiangiogenic tumor therapy following rAAV-mediated gene transfer | |
| P478 | volume | 15 | |